Karamouzis MV - Search Results

1

The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status.

Koustas E, Papavassiliou AG, Karamouzis MV. Koustas E, et al. Among authors: karamouzis mv. PLoS One. 2018 Nov 14;13(11):e0207227. doi: 10.1371/journal.pone.0207227. eCollection 2018. PLoS One. 2018. PMID: 30427914 Free PMC article.

2

Induction of the CBP transcriptional co-activator early during laryngeal carcinogenesis.

Karamouzis MV, Papadas T, Varakis I, Sotiropoulou-Bonikou G, Papavassiliou AG. Karamouzis MV, et al. J Cancer Res Clin Oncol. 2002 Mar;128(3):135-40. doi: 10.1007/s00432-001-0317-y. Epub 2002 Jan 24. J Cancer Res Clin Oncol. 2002. PMID: 11935299

3

Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors.

Karamouzis MV, Likaki-Karatza E, Ravazoula P, Badra FA, Koukouras D, Tzorakoleftherakis E, Papavassiliou AG, Kalofonos HP. Karamouzis MV, et al. Int J Cancer. 2002 Nov 1;102(1):86-90. doi: 10.1002/ijc.10654. Int J Cancer. 2002. PMID: 12353238

4

Retinoid-X-receptor alpha (RXRalpha) expression during laryngeal carcinogenesis: detrimental or beneficial event?

Karamouzis MV, Sotiropoulou-Bonikou G, Vandoros G, Varakis I, Papavassiliou AG. Karamouzis MV, et al. Cancer Lett. 2003 Sep 25;199(2):175-83. doi: 10.1016/s0304-3835(03)00346-x. Cancer Lett. 2003. PMID: 12969790

5

Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues.

Karamouzis MV, Sotiropoulou-Bonikou G, Vandoros G, Varakis I, Papavassiliou AG. Karamouzis MV, et al. Eur J Cancer. 2004 Mar;40(5):761-73. doi: 10.1016/j.ejca.2003.12.002. Eur J Cancer. 2004. PMID: 15010078

6

COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?

Karamouzis MV, Papavassiliou AG. Karamouzis MV, et al. Expert Opin Investig Drugs. 2004 Apr;13(4):359-72. doi: 10.1517/13543784.13.4.359. Expert Opin Investig Drugs. 2004. PMID: 15102586 Review.

7

Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention.

Karamouzis MV, Papavassiliou AG. Karamouzis MV, et al. Trends Mol Med. 2005 Jan;11(1):10-6. doi: 10.1016/j.molmed.2004.11.006. Trends Mol Med. 2005. PMID: 15649817 Review.

8

Novel insights into the implication of the IGF-1 network in prostate cancer.

Papatsoris AG, Karamouzis MV, Papavassiliou AG. Papatsoris AG, et al. Among authors: karamouzis mv. Trends Mol Med. 2005 Feb;11(2):52-5. doi: 10.1016/j.molmed.2004.12.005. Trends Mol Med. 2005. PMID: 15694866 Review.

9

Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC).

Papatsoris AG, Karamouzis MV, Papavassiliou AG. Papatsoris AG, et al. Among authors: karamouzis mv. Curr Med Chem. 2005;12(3):277-96. doi: 10.2174/0929867053363306. Curr Med Chem. 2005. PMID: 15723619 Review.

10

PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas.

Vandoros GP, Konstantinopoulos PA, Sotiropoulou-Bonikou G, Kominea A, Papachristou GI, Karamouzis MV, Gkermpesi M, Varakis I, Papavassiliou AG. Vandoros GP, et al. Among authors: karamouzis mv. J Cancer Res Clin Oncol. 2006 Feb;132(2):76-84. doi: 10.1007/s00432-005-0042-z. Epub 2005 Oct 8. J Cancer Res Clin Oncol. 2006. PMID: 16215757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters